Clinical Drug Experience Knowledgebase

Melanoma

Adenocarcinoma (Phase 2)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Asthma (Phase 2)

Astrocytoma (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 1)

Carcinoma, Renal Cell (Phase 2)

Cardiomegaly (Phase 2)

Cardiomyopathies (Phase 3)

Cardiomyopathy, Dilated (Phase 3)

Cardiomyopathy, Hypertrophic (Phase 2)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 3)

Diabetes Mellitus, Type 2 (Phase 1)

Disease Progression (Phase 1)

Fallopian Tube Neoplasms (Phase 3)

Gastrointestinal Stromal Tumors (Phase 2)

Glioblastoma (Phase 2)

Gliosarcoma (Phase 2)

Hypertrophy (Phase 2)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Plasma Cell (Phase 2)

Liver Diseases (Phase 1)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Melanoma (Phase 3)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neoplasms, Second Primary (Phase 2)

Neurofibroma (Phase 2)

Neurofibroma, Plexiform (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Noonan Syndrome (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pancreatic Neoplasms (Phase 2)

Preleukemia (Phase 1)

Rectal Neoplasms (Phase 2)

Spondylitis (Phase 2)

Spondylitis, Ankylosing (Phase 2)

Syndrome (Phase 1)

Toothache (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Uveal Neoplasms (Phase 2)